News · 26 weeks57+314%
2026-03-012026-08-23
Mix3790d
- Insider27(73%)
- Other4(11%)
- SEC Filings4(11%)
- Earnings1(3%)
- Offering1(3%)
Latest news
25 items- INSIDERLarge owner Sc Us (Ttgp), Ltd. converted options into 1,778,626 shares and disposed of 1,778,626 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERDirector Botha Roelof acquired 55,167 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERCEO and Secretary Colis Peter George converted options into 55,848 shares and sold $2,795,706 worth of shares (84,448 units at $33.11) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,537,360 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERPresident Wang Lingke converted options into 83,197 shares and sold $3,939,733 worth of shares (118,333 units at $33.29) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,537,543 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERChief Accounting Officer Kucharski Brandt Walter sold $283,664 worth of shares (8,735 units at $32.47) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 91,648 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERLarge owner Sc Us (Ttgp), Ltd. converted options into 142,616 shares and sold $4,713,232 worth of shares (142,616 units at $33.05) (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERLarge owner Sc Us (Ttgp), Ltd. sold $4,713,232 worth of shares (142,616 units at $33.05) and converted options into 142,616 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- SECSEC Form 144 filed by Ethos Technologies Inc.144 - Ethos Technologies Inc. (0001788451) (Subject)
- INSIDERDirector Botha Roelof acquired 51,735 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERLarge owner Sc Us (Ttgp), Ltd. converted options into 1,778,626 shares and disposed of 1,778,626 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- PREthos to Present at the Goldman Sachs Communacopia + Technology ConferenceAUSTIN, Texas, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Ethos (NASDAQ:LIFE), a leading life insurance technology company democratizing access to life insurance, today announced that Peter Colis, Co-founder and Chief Executive Officer, will present at the Goldman Sachs Communacopia + Technology Conference. Event Details: Date: Wednesday, September 9, 2026Time: 3:45 PM PT / 6:45 PM ETWebcast: A live audio webcast of the presentation will be available on the Ethos Investor Relations website at investors.ethos.com The presentation will be archived on the company’s investor relations website for 90 days following the event. About Ethos Ethos is a leading life insurance technology company on a mis
- INSIDERPresident Wang Lingke sold $775,626 worth of shares (22,623 units at $34.28), decreasing direct ownership by 1% to 1,572,679 units (SEC Form 4) to satisfy tax liability4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERCEO and Secretary Colis Peter George sold $1,003,014 worth of shares (29,342 units at $34.18), decreasing direct ownership by 2% to 1,565,960 units (SEC Form 4) to cover withholding tax4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERChief Accounting Officer Kucharski Brandt Walter sold $2,896,791 worth of shares (83,047 units at $34.88) as part of a pre-agreed trading plan, decreasing direct ownership by 45% to 100,383 units (SEC Form 4) (tax withholding)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERChief Financial Officer Capozzi Christopher M. sold $893,875 worth of shares (26,184 units at $34.14), decreasing direct ownership by 4% to 639,044 units (SEC Form 4) to satisfy withholding tax4 - Ethos Technologies Inc. (0001788451) (Issuer)
- SECSEC Form 144 filed by Ethos Technologies Inc.144 - Ethos Technologies Inc. (0001788451) (Subject)
- INSIDERLarge owner Accel Growth Fund Iv L.P. converted options into 750,000 shares and disposed of 750,000 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- PREthos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every FamilyAUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ethos (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it has signed its next sports partner, Erin Andrews, Fox Sports NFL reporter, co-host of 99 To Beat, entrepreneur, and cervical cancer survivor. Andrews will serve as a national ambassador for Ethos in an upcoming campaign, details of which will be announced at a later date. "I've spent my career around athletes who prepare obsessively for every possible outcome on the field," said Erin Andrews. "But when it comes to protecting their families financially, so many people, athletes and fans alike, just ha
- INSIDERDirector Mullin Mark W. was granted 6,801 shares, increasing direct ownership by 39% to 24,252 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERDirector Wheeler William J was granted 7,054 shares, increasing direct ownership by 3% to 278,079 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERDirector Hung Priscilla was granted 7,022 shares, increasing direct ownership by 30% to 30,287 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERDirector Kunze John H was granted 7,592 shares, increasing direct ownership by 31% to 31,785 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERDirector Niparko Nathan J was granted 6,927 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERDirector Shipchandler Khozema was granted 7,433 shares, increasing direct ownership by 37% to 27,312 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- INSIDERDirector Botha Roelof was granted 7,592 shares, increasing direct ownership by 3% to 268,117 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
LIFE FAQ
7 questionsWhat does Ethos Technologies Inc. do?
aTyr Pharma, Inc., a clinical stage biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead clinical product candidate is ATYR1923, a selective modulator of NRP2 for the treatment of patients with severe inflammatory lung diseases, including interstitial lung diseases (ILDs) and severe respiratory complications caused by COVID-19. Its product, ATYR1923, is in Phase 1b/2a multi-center clinical trial for pulmonary sarcoidosis. The company is also developing ATYR2810, a fully humanized...Where does LIFE stock trade?
Ethos Technologies Inc. (LIFE) is listed on NASDAQ.What sector and industry is LIFE in?
Ethos Technologies Inc. operates in the Finance sector, Specialty Insurers industry.When did Ethos Technologies Inc. go public?
Ethos Technologies Inc. (LIFE) completed its IPO in 2026.What are analysts saying about LIFE?
Ethos Technologies Inc. has had 8 recent analyst actions on file. The most recent action was from Goldman: Buy with a $3300.00 price target on 2026-02-23. Recent price targets range from $1300.00 to $3300.00.What companies are similar to LIFE?
Notable peers in the same industry include MEIP (MEI Pharma Inc.), EPIX (ESSA Pharma Inc.), EVOK (Evoke Pharma Inc.). Compare LIFE side-by-side with any of them on Quantisnow.How can I track LIFE on Quantisnow?
Quantisnow aggregates Ethos Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LIFE to receive live email and push alerts on every new disclosure.